View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
CPSC | RIN: 3041-AC43 | Publication ID: Spring 2009 |
Title: Inaccessible Component Parts in Children's Products Containing Lead | |
Abstract: Section 101(b)(2)(B) of the Consumer Product Safety Improvement Act of 2008 (CPSIA), Public Law 110-314, 122 Stat. 3016 (August 14, 2008), requires the Commission to promulgate a rule providing guidance with respect to what components, or classes of components, of children's products will be considered to be inaccessible. The CPSIA directs the Commission to promulgate the rule by August 14, 2009. On January 15, 2009, the Commission published a notice of proposed interpretative rule providing guidance on with respect to what product components or classes of components will be considered to be inaccessible under section 101(b) of the Consumer Product Safety Improvement Act of 2008 (CPSIA), Public Law 110-314. The proposed interpretative rule stated that a lead-containing component part would be evaluated on the accessibility of lead-containing component parts of a childrens product as a result of normal and reasonably foreseeable use and abuse of the product by children based on: accessibility probes specified for sharp points or edges under the Commissions regulations at 16 CFR 1500.48-1500.49; and the use and abuse tests set forth under the Commissions regulations at 16 CFR 1500.50-1500.53 (excluding the bite tests of 1500.51(c) and 1500.52(c)) Children's Products Containing Lead: Exemption for Certain Electronic Devices; Notice of Proposed Rulemaking. The notice solicited comments on proposed interpretative rule by February 17, 2008. The Commission staff will review public comments on the proposed rule and prepare a briefing package for Commission consideration. | |
Agency: Consumer Product Safety Commission(CPSC) | Priority: Substantive, Nonsignificant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: Undetermined | Unfunded Mandates: No |
CFR Citation: 16 CFR 1500 | |
Legal Authority: PL 110-314, sec 101(b)(2)(B) |
Legal Deadline:
|
||||||||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: Undetermined | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: No | |
International Impacts: This regulatory action will be likely to have international trade and investment effects, or otherwise be of international interest. | |
RIN Data Printed in the FR: No | |
Agency Contact: Kristina M. Hatlelid Ph.D. Project Manager Consumer Product Safety Commission Directorate for Health Sciences, 5 Research Place, Rockville, MD 20850 Phone:301 987-2558 Email: khatlelid@cpsc.gov |